#1 Clinical Trials Search in Europe

Lactulose

Lactulose, a synthetic sugar used primarily as a laxative and to treat hepatic encephalopathy, has been the subject of several clinical trials exploring its efficacy in various medical conditions. These trials have investigated lactulose’s potential in bowel preparation for colonoscopy, treatment of constipation, prevention of hepatic encephalopathy, and management of acute-on-chronic liver failure. The studies have compared lactulose to other treatments and explored its effectiveness when combined with other medications.

Table of Contents

What is Lactulose?

Lactulose is a synthetic sugar that is not easily digested by the human body. It’s classified as a laxative and is used to treat various medical conditions[1]. Lactulose is available in different forms, including a liquid solution and a crystallized form known as Kristalose[2]. Other brand names for lactulose include Chronulac, Constilac, Constulose, Duphalac, and Evalose[1].

Medical Uses of Lactulose

Lactulose is used to treat several conditions:

  • Constipation: Lactulose is commonly used to relieve constipation, especially in patients who have undergone surgery like Caesarean sections[3].
  • Hepatic Encephalopathy: This is a serious condition where liver problems affect brain function. Lactulose is used to prevent and treat hepatic encephalopathy in patients with cirrhosis (scarring of the liver)[4][5].
  • Bowel Preparation: Lactulose is sometimes used to clean out the bowels before medical procedures like colonoscopies[6].
  • Chronic Kidney Disease (CKD): Some research is exploring the use of lactulose in patients with chronic kidney disease to improve certain health parameters[7].

How Lactulose Works

Lactulose works in several ways:

  • As a Laxative: Lactulose is not absorbed well by the body. When it reaches the colon, it draws water into the intestines, which softens the stool and makes it easier to pass[1].
  • Altering Gut Bacteria: Lactulose can change the balance of bacteria in the gut. It increases the number of beneficial bacteria like Bifidobacteria and Lactobacilli[8].
  • Reducing Harmful Substances: In patients with liver problems, lactulose helps reduce the amount of ammonia in the blood. Ammonia is a toxic substance that can affect brain function when the liver can’t remove it properly[4].

How Lactulose is Administered

Lactulose is usually taken orally (by mouth). The dosage and frequency can vary depending on the condition being treated and the individual patient. Here are some common ways it’s administered:

  • For constipation, a typical dose might be 15-30 mL of lactulose solution taken once or twice daily[3].
  • For hepatic encephalopathy, doses can be higher, sometimes up to 30-60 mL taken 2-3 times a day[4].
  • In some cases, lactulose may be given as an enema (a liquid treatment introduced into the rectum)[8].
  • The crystallized form (Kristalose) is usually dissolved in water or another beverage before taking[2].

It’s important to follow your doctor’s instructions carefully when taking lactulose.

Potential Side Effects

Like all medications, lactulose can cause side effects. Common side effects include:

  • Bloating and gas
  • Nausea
  • Stomach cramps
  • Diarrhea

In high doses, lactulose can cause more severe side effects such as dehydration and electrolyte imbalances. It’s important to discuss any side effects with your healthcare provider[9].

Ongoing Research

Researchers continue to study lactulose for various uses:

  • Comparing lactulose to other treatments for hepatic encephalopathy[1].
  • Investigating whether lactulose can improve quality of life in patients with cirrhosis[5].
  • Studying the effects of lactulose on patients with chronic kidney disease[7].
  • Exploring new combinations of lactulose with other substances for bowel preparation before colonoscopy[10].

These ongoing studies may lead to new uses or improved understanding of how lactulose can be used most effectively in different medical conditions.

Aspect Details
Primary Uses in Trials Bowel preparation for colonoscopy, treatment of constipation, prevention and management of hepatic encephalopathy, acute-on-chronic liver failure management
Administration Methods Liquid form, crystal form dissolved in water, enema
Dosage Range Varies by study: 15-60 ml once or twice daily, up to more frequent doses in some trials
Comparative Treatments Polyethylene glycol (PEG), rifaximin, AST-120
Key Outcome Measures Boston Bowel Preparation Scale, Westhaven Scale, ammonia levels, quality of life assessments, adenoma detection rate
Common Side Effects Bloating, gas, diarrhea, potential for nausea and abdominal pain
Special Considerations Potential for dehydration and electrolyte imbalances with high doses, need for proper dosing and monitoring

FAQ

  • What is lactulose and how does it work? Lactulose is a synthetic sugar that is not absorbed by the body. It works by drawing water into the colon, which softens stools and promotes bowel movements. In liver conditions, it helps reduce the amount of ammonia in the blood by changing the acidity in the intestines.
  • In which medical conditions is lactulose being studied? Clinical trials are investigating lactulose for various conditions, including bowel preparation before colonoscopy, treatment of constipation (especially after Caesarean sections), prevention and treatment of hepatic encephalopathy in cirrhosis patients, and management of acute-on-chronic liver failure.
  • How is lactulose administered in these clinical trials? The administration of lactulose varies depending on the study and condition. It may be given as a liquid, in crystal form dissolved in water, or as an enema. Dosages and frequency also vary, ranging from 15-60 ml once or twice daily to more frequent doses in some studies.
  • Are there any side effects associated with lactulose use? Common side effects of lactulose can include bloating, gas, and diarrhea. In some cases, it may cause nausea, vomiting, or abdominal pain. High doses can potentially lead to dehydration and electrolyte imbalances, which is why proper dosing and monitoring are important.
  • How does lactulose compare to other treatments in these trials? Some trials compare lactulose to other treatments like polyethylene glycol (PEG) or rifaximin. The effectiveness of lactulose varies depending on the condition being treated. For example, in hepatic encephalopathy, it's being compared to newer treatments to determine the best approach for patients.

Ongoing Clinical Trials on Lactulose

  • Study on Preventing Hepatic Encephalopathy with Rifaximin and Lactulose in Patients with Alcoholic Liver Cirrhosis Undergoing TIPS Placement

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium The Netherlands

Glossary

  • Hepatic Encephalopathy: A decline in brain function that occurs as a complication of liver disease, often due to the liver's reduced ability to remove toxins from the blood.
  • Cirrhosis: A late stage of scarring (fibrosis) of the liver caused by many forms of liver diseases and conditions, such as hepatitis and chronic alcoholism.
  • Bowel Preparation: The process of cleansing the bowel before a medical examination or procedure, typically a colonoscopy, to ensure clear visibility of the colon lining.
  • Acute-on-Chronic Liver Failure (ACLF): A syndrome characterized by acute decompensation of chronic liver disease associated with organ failures and high short-term mortality.
  • Boston Bowel Preparation Scale: A scoring system used to assess the quality of bowel preparation during colonoscopy, ranging from 0 (unprepared colon) to 9 (perfectly clean colon).
  • Adenoma Detection Rate (ADR): The proportion of colonoscopies where at least one adenoma (a type of polyp that can develop into cancer) is found and removed.
  • Kristalose: A brand name for crystalline lactulose, which is a form of lactulose that comes as a powder to be dissolved in liquid before use.
  • Polyethylene Glycol (PEG): A laxative solution often used for bowel preparation before colonoscopy or to treat constipation.
  • Rifaximin: An antibiotic medication sometimes used in combination with lactulose for the treatment of hepatic encephalopathy.
  • Westhaven Scale: A grading system used to assess the severity of hepatic encephalopathy, ranging from grade 0 (no impairment) to grade 4 (coma).

References

  1. https://clinicaltrials.gov/study/NCT00558038
  2. https://clinicaltrials.gov/study/NCT00712543
  3. https://clinicaltrials.gov/study/NCT01295138
  4. https://clinicaltrials.gov/study/NCT01175538
  5. https://clinicaltrials.gov/study/NCT05061992
  6. https://clinicaltrials.gov/study/NCT01256541
  7. https://clinicaltrials.gov/study/NCT05934552
  8. https://clinicaltrials.gov/study/NCT02321371
  9. https://clinicaltrials.gov/study/NCT00914056
  10. https://clinicaltrials.gov/study/NCT05498714